Navigation Links
Economic Stimulus Law Weakens Americans' Control Over Personal Health Information

WASHINGTON, March 26 /PRNewswire-USNewswire/ -- While it is touted as a major tool for lowering health care costs, the Electronic Health Record (EHR) has serious implications for Americans' health privacy. The Institute for Health Freedom (IHF) warns that the economic stimulus law (H.R. 1, Public Law No. 111-5) weakens individuals' control over the flow of their personal health information. "The economic stimulus law plans for every American to use an electronic health record (EHR) and allows those records to be sold for research and public-health purposes -- without patients' consent," said Sue Blevins, IHF president.

"According to some health IT experts, we're entering a 'gold rush' era for health data," Blevins noted. "Sophisticated data-management techniques make it increasingly easy to share individuals' most sensitive health data -- including genetic information -- without their knowing it. The EHR further enables this sharing. That is why addressing patient ownership and consent rights are essential. Such rights will determine whether Americans will either 'own or be owned, control or be controlled' when it comes to their genetic and other personal health data."

"Unfortunately, the economic stimulus law does not guarantee that individuals own and control their genetic and other personal health data. Thus, Congress should act soon to make sure Americans have individual ownership rights and full control over their personal health data as we move toward adopting EHR systems," she said.

IHF released a side-by-side comparison of key aspects of the federal HIPAA privacy rule and the privacy provisions in the economic stimulus law (see:

The comparison shows clearly that the new law does not give citizens final say in who can access their personal health information. "As it stands, the HIPAA law allows individuals' data to be disclosed to more than 600,000 health-related organizations -- without patients' consent. And the economic stimulus law did not close this huge gap," noted Blevins. "Let's hope Congress fixes this soon by ensuring ownership rights and patient-consent rights regarding the disclosure of Americans' personal health information -- including genetic information."

Moreover, IHF points out that most members of Congress didn't have time to read the economic stimulus bill before voting on it. And President Obama didn't read the bill in its entirety before signing it into law, according to a CBS News report. "IHF urges Congress and President Obama to read thoroughly future bills before voting and signing them into law. Also, the American public should receive at least one week to study proposed laws so they can share their informed views with their elected officials. Our health privacy rights are vital and deserve thoughtful and well-informed policymaking," Blevins said.

The Institute for Health Freedom (IHF) ( is national nonprofit, educational organization whose mission is to bring the issues of personal health freedom to the forefront of the American health-policy debate. IHF monitors and reports on national policies that affect citizens' freedom to choose their health-care treatments and providers, and to maintain their health privacy -- including genetic privacy.

    Sue Blevins, President
    ph: (202) 429-6610

SOURCE Institute for Health Freedom
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
2. McKesson Corporation CEO to Address the Detroit Economic Club on Preserving Our Healthcare System and Improving Quality of Life
3. Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development
4. AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. Economic motivation may affect how often some physicians order imaging studies
7. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
8. Through-Wave Ultrasound: Effective, Economical and Ideal for Breast Imaging, Biopsy
9. MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements
10. Skatepark injuries can incur economic pain
11. AARP Calls New EEOC Policy A Civil Rights and Economic Fiasco
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: